Trial intelligence / Profile preview

LIBRA: Detemir vs Glargine on Endothelial Function in T2DM

NCT00699686Phase 4Completed

Sponsor
Università di Padova
Start
May 2008
Primary completion
Mar 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of insulin detemir in type 2 diabetes mellitus (T2DM), sponsored by Università di Padova. Started May 2008; status: completed.

02

Drugs

insulin detemir
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00699686.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00699686.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call